Andrew Oxtoby Net Worth & Insider Trades

Andrew Oxtoby - Chief Commercial Officer, Aimmune Therapeutics, Inc

As of October 14, 2020

What is Andrew Oxtoby's Net Worth?

The current estimated net worth of Aimmune Therapeutics, Inc's Chief Commercial Officer, Andrew Oxtoby, is estimated to be about $0 . Andrew Oxtoby owns about 25,015 units of Aimmune Therapeutics, Inc common stock. In the last year at Aimmune Therapeutics, Inc, Andrew Oxtoby has sold an estimated value of $987.34K worth.

What is Andrew Oxtoby's Past Insider Trading?

Andrew Oxtoby's largest purchase order was 3,000 units , worth over $44.27K on March 17, 2020. In total, Andrew Oxtoby has made about 7 transactions over a year of their time at Aimmune Therapeutics, Inc. Andrew Oxtoby usually trades in March, with the busiest year in 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Andrew Oxtoby

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Andrew Oxtoby's' Mailing Address?

  • Mailing address is 8000 Marina Boulevard Suite 300 Brisbane CA 94005 CA

What are Aimmune Therapeutics, Inc's Past Insider Trades?

Aimmune Therapeutics, Inc's most recent insider trade came on October 15, 2020 by Societe Des Produits Nestle S.A. Claudio Kuoni who bought 54,117,287 units worth $1.87B . In the last 5 years, insiders at Aimmune Therapeutics, Inc have sold an estimated value of $72.67M and bought an estimated value of $2.52B worth of shares. Insider trading is most common in May, with the busiest year in 2020. The most active traders at the company are Douglas T Sheehy, See Remarks,  Daniel C. Adelman, Chief Medical Officer,  and Eric Bjerkholt, Chief Financial Officer .

Aimmune Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...